A Randomized Controlled Pilot Study to Examine the Use of Micrografting, Using a Novel Grafting Technique for the Repigmentation of Vitiligo
Where: Massachusetts General Hospital
Description: The Dermatology Clinical Unit for Research Trials is recruiting subjects 18 years of age and older with vitiligo. The purpose is to study the use of micrografting technique in patients with vitiligo.
The study may last up to 24 weeks and requires about 8 study visits. You will receive up to $550 for participating in this study.
Eligibility Criteria: Subject of 18 years of age and older has 3 comparable vitiliginous areas of trunk or extremities (excluding hands) each measuring at least 3cm×3cm in size, with at least 80% depigmentation, and anticipated equal sun exposure. If you are currently taking certain medications for vitiligo, you may not be eligible for this trial. Please consult your doctor. Other restrictions will be explained at the screening visit.
Principle Investigator: Alexandra B. Kimball MD, MPH
Enrollment Information: For further information about participating in this trial, contact Lynne at (617) 726-5066 or email harvardskinstudies@partners.org
[ad#post-bottom]